
pmid: 21081731
Clinical Trials as Topic, Time Factors, Drug Industry, United States Food and Drug Administration, Decision Making, Politics, United States, Midodrine, Safety-Based Drug Withdrawals, Product Surveillance, Postmarketing, Humans, Adrenergic alpha-1 Receptor Agonists, Drug Approval, Biomarkers
Clinical Trials as Topic, Time Factors, Drug Industry, United States Food and Drug Administration, Decision Making, Politics, United States, Midodrine, Safety-Based Drug Withdrawals, Product Surveillance, Postmarketing, Humans, Adrenergic alpha-1 Receptor Agonists, Drug Approval, Biomarkers
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 38 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
